Skip to content
value.today

Mangoceuticals, Inc.

Total raised
$2 M
1 round on record
Latest round
$2 M
Aug 2022
First round on record
Aug 2022
Today
Went public
See the company page

Mangoceuticals, Inc. is listed today as Mangoceuticals, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Mangoceuticals, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2022$2 MNo. 1Under $2 million

Mangoceuticals, Inc.: Raise no. 1, Aug 2022

Investors in this round

19 investors had bought by the notice of Oct 11, 2022: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$120,040
Finders' fees
none
Paid to its own people
$20,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Texas

People named in the notice

  • Jacob Cohen · Executive Officer, Director
  • Jonathan Arango · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Boustead Securities, LLC (CRD 141391) · Irvine, CaliforniaSold in AZ, CA, FL, NV, NY, TX

Remarks in the notice

  • On fees: “Includes 1% non-accountable expense. Does not include warrants to purchase 7% of the shares and warrants sold in the offering, also granted to the placement agent.”

Signed by Jacob Cohen, Ceo. Newest notice filed Oct 11, 2022. Read the notice at the SEC.

equity, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Mangoceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2022).

    SEC Form D · Oct 2022

  • The industry group it chose in its notices: Other.

    SEC Form D · Oct 2022

Products and services#

No products or services of Mangoceuticals, Inc. are on record.

Investors#

No investor of Mangoceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Largest shareholders today

Institutions holding Mangoceuticals, Inc. shares, as of Sep 30, 2026.

As of Sep 30, 2026

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Mangoceuticals, Inc.
NameRoleNamed in
Jacob CohenExecutive officerOct 2022
Jonathan ArangoExecutive officerOct 2022
Jacob CohenDirectorOct 2022
Jonathan ArangoDirectorOct 2022

Went public since 2023. Its SEC number is that of a company listed on a stock exchange.